期刊信息/Journal information
：清华大学
：Jiahong Dong
：季刊
：2772-9478
：10-1764/R
：iliver@tup.tsinghua.edu.cn
：100084
：Room 902, Building A, Xueyan Building, Haidian District, Beijing 100084, China
iLIVER/Journal 国际肝胆健康（英文）
诞生于健康中国和国际肝脏学蓬勃发展背景下的iLIVER，聚焦肝胆系统的临床医学、转化医学、基础医学和公共卫生学的重要原创研究，编委团队汇聚来自全球18个国家的、从事临床、预防、基础、转化或交叉研究的卓...展开全部>>
收录年代
Exploring emerging frontiers in hepatology:iLIVER''''s continuing journey
Ming-Da Wang;Xin-Fei Xu;Lei Cai;Tian Yang;P.1-3
Duodenal varices and evaluation of endoscopic cyanoacrylate injection for treatment of duodenal variceal bleeding
Jin-dong Chu;Qian Bi;Yan-ling Wang;Xue-mei Ma;Bo Liu;Liang Wu;Shuai Wang;Li-jun Shen;Xiao-bao Qi;Zheng Lu;P.23-28
Detection of metabolic signatures implicated in the progression from hepatitis to cirrhosis to hepatocellular carcinoma
Simiao Yu;Sici Wang;Jiahui Li;Haocheng Zheng;Ping Li;Wenya Rong;Jing Jing;Tingting He;Yongqiang Sun;Liping Wang;Zhenyu Zhu;Xia Ding;Ruilin Wang;P.15-22
Itaconate facilitates methane-induced Nrf2 pathway activation for mitigating liver ischemia and reperfusion injury
Tianyi Zhang;Danfeng Fan;Kewei Qin;Hongtao Lu;Linwei Zhao;Kexin Liu;Pei Zhang;Qiang Sun;Zhouheng Ye;P.38-45
Emerging role of natural bioactive compounds in navigating the future of liver disease
Neha Chaudhary;Muhammad Arif;Sheeba Shafi;Shom Prakash Kushwaha;Pushpendra Soni;P.4-14
Treatment for unresectable hepatocellular carcinoma patients:Options and management after complete response
Jin-Ming Wang;Guo-Gao Qiu;Zhi-Dong Liu;Jia-Yong Su;Da-Long Yang;Zhu-Jian Deng;Zhi-Cheng Li;Jian-Hong Zhong;P.52-54
Contrast-enhanced US and contrast-enhanced CT for diagnosis of focal liver lesions in liver transplant recipients:A comparative study
Nong Gao;Dongli Wang;Xiuzhu Ma;Faqin Lv;Xiuyun Ren;P.46-51
MAGI2-AS3/miR-450b-5p/COLEC10 interaction network:A potential therapeutic and prognostic marker in hepatocellular carcinoma
Lan-Qing Yao;Yong-Kang Diao;Jin-Bo Gong;Li-Hui Gu;Jia-Hao Xu;MingDa Wang;Chao Li;P.29-37